| HOME >> MEDICINE >> TECHNOLOGY |
8.2.12 SnapPath Biomarker Testing System: BioMarker Strategies 42
8.2.13 Scobe-E System: Oncoscope, Inc. 42
8.2.14 Verisante Core: Verisante Technology, Inc. 43
8.2.15 Verisante Aura: Verisante Technology, Inc. 43
8.2.16 WavStat - Bladder Cancer: SpectraScience, Inc. 43
8.2.17 WavStat - Esophageal Cancer: SpectraScience, Inc. 44
8.2.18 WavStat - Gastric Cancer: SpectraScience, Inc. 44
8.2.19 WavStat - Inflammatory Bowel Syndrome: SpectraScience, Inc. 45
8.2.20 WavStat - Lung Cancer: SpectraScience, Inc. 45
8.2.21 WavStat - Pancreatic Cancer: SpectraScience, Inc. 45
8.2.22 WavStat - Skin Cancer: SpectraScience, Inc. 46
9 Biopsy Devices Market - Deals Landscape 47
9.1 Biopsy Devices Market, Key Deals, 2007–2011 47
9.1.1 Ums United Medical Acquires Mobile Biopsy, 2011 47
9.1.2 C. R. Bard Acquires SenoRx for $213m, 2010 48
9.1.3 C. R. Bard Acquires Assets from Inrad, 2007 48
9.1.4 iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49
9.1.5 Abnova Enters into Co-Development Agreement with Clearbridge BioMedics, 2011 49
9.1.6 Ethicon Endo-Surgery Completes Sale of Breast Care Business to Devicor Medical Products, 2010 50
9.1.7 Varian Medical Systems Acquires Pan-Pacific Enterprises, 2007 51
9.1.8 Hologic Acquires Suros Surgical Systems, 2006 51
9.1.9 Hologic Sells Intellectual Property of Mammotest System to Siemens, 2006 52
10 Appendix 53
10.1 Definitions 53
10.1.1 Biopsy Devices 53
10.2 Acronyms 54
10.3 Sources 54
10.4 Research Methodology 55
10.4.1 Secondary Research 55
10.4.2 Primary Research 56
10.4.3 Models 56
10.4.4 Forecasts 56
10.4.5 Expert Panels 56
10.5 GlobalData Consulting 57
10.6 Contact Us 57
10.7 Disclaimer 57
List of Tables
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |